Tag Archives: XERS

Analysts Have Conflicting Sentiments on These Healthcare Companies: Xeris Pharmaceuticals (NASDAQ: XERS) and Evolus (NASDAQ: EOLS)

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Xeris Pharmaceuticals (XERS – Research Report) and Evolus (EOLS – Research Report). Xeris Pharmaceuticals (XERS) In a report released today, Difei Yang from Mizuho Securities

RBC Capital Reiterates Outperform on Xeris Pharmaceuticals Shares, Sees 475% Upside For The Stock

In a research report released on 5/20, RBC Capital analyst Randall Stanicky reiterated an Outperform rating on Xeris Pharmaceuticals (NASDAQ:XERS)with a price target of $15, which represents a potential upside of 475% from where the stock is currently trading. According

Leerink Partners Reiterates Buy on Xeris Pharmaceuticals Shares, Sees 273% Upside For The Stock

In a research report released on 6/18, Leerink Partners analyst Ami Fadia reiterated a Buy rating on Xeris Pharmaceuticals (NASDAQ:XERS)with a price target of $10, which implies an upside of 273% from current levels. According to TipRanks.com, which measures analysts’

Mizuho Securities Thinks Xeris Pharmaceuticals’ Stock is Going to Recover

In a report released today, Difei Yang from Mizuho Securities maintained a Buy rating on Xeris Pharmaceuticals (XERS – Research Report), with a price target of $14.00. The company’s shares closed last Wednesday at $1.67, close to its 52-week low

Mizuho Securities Maintains a Buy Rating on Xeris Pharmaceuticals (XERS)

Mizuho Securities analyst Difei Yang maintained a Buy rating on Xeris Pharmaceuticals (XERS – Research Report) today and set a price target of $18.00. The company’s shares closed last Thursday at $1.56, close to its 52-week low of $1.42. According

Xeris Pharmaceuticals (XERS) Receives a Buy from Mizuho Securities

Mizuho Securities analyst Difei Yang maintained a Buy rating on Xeris Pharmaceuticals (XERS – Research Report) today and set a price target of $22.00. The company’s shares closed last Monday at $6.16, close to its 52-week low of $5.30. According